BeOne Medicines Ltd. (ONC) financial statements and ratios from SEC XBRL: revenue $6.1B (TTM), net margin 5.4%, revenue growth 29.6% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $5.34B |
| Revenue (TTM) | $6.1B |
| Net Margin | 5.4% |
| Return on Equity | 12.7% |
| Operating Margin (TTM) | 15.1% |
| Debt / Equity | 0.18 |
| Current Ratio | 3.40 |
| Net Debt / EBITDA | -4.0 |
| Interest Coverage | 8.0 |
| Revenue Growth (YoY) | 29.6% |
| EPS Growth (YoY) | 128.6% |
| FCF Growth (YoY) | 187.2% |
| Altman Z-Score | 78.49 (safe) |
| Industry P/E (Pharmaceutical Products) | 15.1 |
| Sector P/E (Healthcare) | 19.4 |
ONC overview · ONC earnings · ONC KPIs · ONC documents · ONC ownership · ONC peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.